Literature DB >> 23982226

CpG oligodeoxynucleotide induces bone marrow precursor cells into myeloid-derived suppressor cells.

Jie Chen1, Chengyu Deng, Qingmin Shi, Jun Jiang, Yongbo Zhang, Wei Shan, Weimin Sun.   

Abstract

Dendritic cells (DCs) and myeloid-derived suppressor cells (MDSCs) perform a number of functions in different immunological settings. In standard in vitro experiments, DCs are produced from mouse bone marrow (BM) cells in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-4. Our previous study demonstrated that BM precursor cells could differentiate into MDSCs when co-cultured with poly (I:C). In the present study, BM precursor cells cultured in GM-CSF and IL-4 were treated with CpG oligodeoxynucleotide (CpG ODN). We observed that Gr1+CD11b+ cells exhibiting MDSC functions accumulated in the co-culture system. A similar phenomenon was also observed in Listeria monocytogenes-infected mice. In conclusion, we demonstrated that prolonged CpG ODN stimulation could inhibit the development of DCs and induce the differentiation of BM precursor cells into MDSCs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23982226     DOI: 10.3892/mmr.2013.1655

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  4 in total

1.  Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccination.

Authors:  Annkristin Heine; Chrystel Flores; Heidrun Gevensleben; Linda Diehl; Mathias Heikenwalder; Marc Ringelhan; Klaus-Peter Janssen; Ulrich Nitsche; Natalio Garbi; Peter Brossart; Percy A Knolle; Christian Kurts; Bastian Höchst
Journal:  Oncoimmunology       Date:  2017-06-16       Impact factor: 8.110

Review 2.  The Role of Myeloid-Derived Suppressor Cells in Viral Infection.

Authors:  Megan A O'Connor; Jessica L Rastad; William R Green
Journal:  Viral Immunol       Date:  2017-01-04       Impact factor: 2.257

Review 3.  Modulation of Immunosuppression by Oligonucleotide-Based Molecules and Small Molecules Targeting Myeloid-Derived Suppressor Cells.

Authors:  Jihyun Lim; Aram Lee; Hee Gu Lee; Jong-Seok Lim
Journal:  Biomol Ther (Seoul)       Date:  2020-01-01       Impact factor: 4.634

4.  In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanoma.

Authors:  Bas D Koster; Tamarah D de Jong; Mari F C M van den Hout; Berbel J R Sluijter; Ronald J C L M Vuylsteke; Barbara G Molenkamp; Saskia Vosslamber; M Petrousjka van den Tol; Alfons J M van den Eertwegh; Tanja D de Gruijl
Journal:  Oncoimmunology       Date:  2019-12-26       Impact factor: 8.110

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.